Leading Medical Device Companies Select Brainshark to Drive Sales Productivity

Acclaimed Sales Enablement Platform Reduces Sales Process Complexities and Helps Companies Close More Deals Faster

Jan 19, 2016, 09:00 ET from Brainshark, Inc.

WALTHAM, Mass., Jan. 19, 2016 /PRNewswire/-- Brainshark, Inc., delivering SaaS-based sales enablement solutions, today announced widespread selection of the Brainshark Sales Accelerator among leading-edge medical device companies. Operating in a highly regulated, rapidly changing and competitive industry, these organizations are using Brainshark to increase sales readiness, reduce complexity in the selling process and close more deals faster.

Medical device companies that recently chose the Brainshark Sales Accelerator include Apollo Endosurgery, Capsule, Clinical Innovations, iRhythm Technologies, MobilityWorks, Teleflex and VisionCare.

"Our sales reps need to demonstrate our innovative wearable, digital and mobile healthcare solutions – including how they can cut costs and improve the course of treatment – to physicians, clinical staffs and other buyers who are pressed for time," said Carrie Shales, director of education and training, iRhythm, a world leader in cardiac arrhythmia information. "We chose the Brainshark Sales Accelerator to equip our sales team to have even more valuable conversations. In particular, the streamlined onboarding and training capabilities, access to the right sales content at the right time and in-depth content analytics make the solution a great fit – while the tight integration with Salesforce will maximize our CRM investments."

Named a "Best New Product of the Year" last month by Best in Biz Awards, the Brainshark Sales Accelerator provides resources for sales onboarding, continuous training, prospecting, live presentation delivery, coaching and content development – all centrally accessible within Salesforce. Powerful analytics give actionable insights into how deals are won.

"Medical device sales teams need to keep abreast of rapidly changing regulations, risks and industry trends that are driving the development of state-of-the-art products – all while showing how their solutions can improve processes and patient outcomes," said Joe Gustafson, Brainshark CEO. "That's why it's so important to have a comprehensive, consolidated solution like the Brainshark Sales Accelerator that addresses every facet of sales enablement. We look forward to helping these companies close more deals, and bring their pioneering and important technologies to even more patients and clinicians."

In addition to medical technology, the Brainshark Sales Accelerator is widely used in financial services, insurance, manufacturing, healthcare and technology industries, among other sectors. For more information about the Brainshark Sales Accelerator, please see www.brainshark.com/solutions/sales-accelerator. A brief video demonstration is also available at www.brainshark.com/see-a-demo.

About Brainshark, Inc.
Brainshark sales enablement solutions help organizations harness the power of content to achieve faster training, better coaching and more successful sales conversations. Using Brainshark to simplify content creation and delivery, companies can ensure salespeople are always up-to-date with the information and resources they need – anytime, anywhere and from any device. Tight integration with Salesforce empowers reps with fast, easy access to the right content and training for every selling situation. Brainshark's detailed analytics also help companies tie content directly to revenue and identify the best sales opportunities, while enabling managers to pinpoint best practices to improve coaching effectiveness. Thousands of companies – including half of the Fortune 100 – rely on Brainshark to improve sales productivity and increase the impact of their sales, marketing and training communications. Learn more at http://www.brainshark.com/.


Brendan Cournoyer

Brainshark, Inc.




Sara Card




Logo - http://photos.prnewswire.com/prn/20120402/NE79983LOGO

SOURCE Brainshark, Inc.